D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.97% |
| 2 | Communication Services | 9.3% |
| 3 | Healthcare | 8.21% |
| 4 | Consumer Discretionary | 8.05% |
| 5 | Energy | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CALL
Biogen
BIIB
$31.9B
| $66M | 0.09% |
215,900
+33,800
| +19% | +$10.7M |
|
227
PUT
Halliburton
HAL
$29.7B
| $66M | 0.09% |
1,120,500
-966,000
| -46% | -$51.6M |
|
228
CALL
JPMorgan Chase
JPM
$937B
| $65.9M | 0.09% |
1,084,800
-619,600
| -36% | -$35.8M |
|
229
NCR Voyix
VYX
$1.04B
| $65.6M | 0.09% |
2,924,375
-1,365,695
| -32% | -$29M |
|
|
CELG
230
DELISTED
Celgene Corp
CELG
| $65.5M | 0.09% |
938,582
+193,080
| +26% | +$15.3M |
|
231
Goldman Sachs
GS
$284B
| $65.3M | 0.09% |
398,461
+329,281
| +476% | +$55.4M |
|
232
Delek US
DK
$4.78B
| $65.2M | 0.09% |
2,244,109
+894,109
| +66% | +$27M |
|
|
BHI
233
DELISTED
Baker Hughes
BHI
| $64.8M | 0.09% |
996,399
-274,644
| -22% | -$16.2M |
|
234
Mondelez International
MDLZ
$79.3B
| $64.7M | 0.09% |
1,873,498
+1,027,927
| +122% | +$35.1M |
|
235
CALL
Qualcomm
QCOM
$201B
| $64.4M | 0.09% |
816,600
+540,000
| +195% | +$40.7M |
|
|
FTR
236
DELISTED
Frontier Communications Corp.
FTR
| $64.2M | 0.09% |
751,002
+95,497
| +15% | +$6.99M |
|
|
LSI
237
DELISTED
LSI CORPORATION
LSI
| $63.1M | 0.09% |
5,703,267
-1,329,978
| -19% | -$14.7M |
|
238
PUT
Verizon
VZ
$214B
| $62.8M | 0.09% |
1,320,800
+498,400
| +61% | +$23.6M |
|
|
AGN
239
DELISTED
Allergan plc
AGN
| $62.7M | 0.09% |
304,570
+295,855
| +3,395% | +$58.6M |
|
240
MSCI
MSCI
$39.6B
| $62.4M | 0.09% |
1,450,962
+204,862
| +16% | +$8.93M |
|
241
Lear
LEA
$6.22B
| $62.3M | 0.09% |
744,210
-585,413
| -44% | -$46.6M |
|
242
PUT
Morgan Stanley
MS
$324B
| $61.6M | 0.09% |
1,975,300
-2,832,800
| -59% | -$87.5M |
|
|
WBA
243
DELISTED
Walgreens Boots Alliance
WBA
| $61.5M | 0.09% |
931,475
-991,412
| -52% | -$62.3M |
|
244
H&R Block
HRB
$5.65B
| $61.1M | 0.09% |
2,022,565
-594,160
| -23% | -$17.8M |
|
245
Trane Technologies
TT
$93B
| $60.6M | 0.09% |
1,058,655
-122,571
| -10% | -$7.3M |
|
|
246
Halliburton
HAL
$29.7B
| $60.5M | 0.09% |
1,027,968
+135,291
| +15% | +$7.23M |
|
247
PUT
Regeneron Pharmaceuticals
REGN
$79.7B
| $60.1M | 0.09% |
200,100
-67,800
| -25% | -$20.9M |
|
248
First Solar
FSLR
$21.7B
| $60M | 0.09% |
860,300
-246,847
| -22% | -$13.8M |
|
249
Sensata Technologies
ST
$6.06B
| $59.9M | 0.09% |
1,405,889
-190,624
| -12% | -$7.6M |
|
250
Archer Daniels Midland
ADM
$41.7B
| $59.9M | 0.09% |
1,380,299
+459,294
| +50% | +$18.9M |
|
Similar funds
D.E. Shaw & Co's Q1 2014 Portfolio in Review
As of Q1 2014, D.E. Shaw & Co held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co deployed $3.3B of net new capital in Q1 2014, opening 596 new positions and adding to 1,359 existing holdings. Its largest new stake was Veren: 1,596,878 shares worth $53.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 44% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $453M trimmed.
- D.E. Shaw & Co's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- D.E. Shaw & Co added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- D.E. Shaw & Co's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- D.E. Shaw & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- D.E. Shaw & Co opened 596 new positions and closed 795 in Q1 2014.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.